None listed
Conditions
Interventions
Medical Device : Subjects will receive total 3 times monthly laser treatment on both sides of the face using Lutronic Clarity II Laser (alexandrite mode 2 passes). Topical anesthesia with EMLA cream (
Sponsors
Yonsei University Health System, Severance Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Adults aged 19-65 2) Individuals with cutaneous vascular lesions (flushing, rosacea) 3) Individuals who understands the purpose and methods of this trial 4) Individuals who can regularly visit our hospital 5) Individuals who agrees to avoid any other dermatologic therapies other than our treatment material
Exclusion criteria
Exclusion criteria: 1) Whom denies to participate 2) Whom allergic to topical anesthesia (lidocaine) 3) Pregnant women, breast feeding women 4) Subjects judged to be unsuitable by the person in charge of the clinical trial for the following conditions ? In case of infectious or inflammatory skin disease at the treatment site ? In case of pigmented skin diseases such as spots at the treatment site ? In case of keloid or collagen or elastic fiber disease ? In case of chronic wasting disease (asthma, diabetes, etc.) ? Risk of bleeding by taking an anticoagulant ? In case of an autoimmune disease ? Person with psychiatric problems ? Person with acute illness 5) Other cases when it is difficult to conduct the clinical (ex. illiteracy, foreigners)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 5-point scale Global Aesthetic Improvement Scale (GAIS) evaluated based on clinical photos | — |
Secondary
| Measure | Time frame |
|---|---|
| Mark-vu, Mexameter, subjective improvement graded by participants | — |
Countries
Korea, Republic of
Contacts
Public ContactPark Sujin
Yonsei University Health System, Severance Hospital
Outcome results
None listed